Conformational studies of neurohypophyseal hormones analogues with glycoconjugates by NMR spectroscopy

被引:3
作者
Lubecka, Emilia A. [1 ]
Sikorska, Emilia [1 ]
Marcinkowska, Alina [1 ]
Ciarkowski, Jerzy [1 ]
机构
[1] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland
关键词
glycosylated analogues; neurohypophyseal hormones; oxytocin; vasopressin; NMR spectroscopy; molecular dynamics; ARGININE-VASOPRESSIN; CHEMICAL-SHIFTS; BIOLOGICAL-ACTIVITY; COUPLING-CONSTANTS; LYSINE-VASOPRESSIN; OXYTOCIN; PEPTIDE; DYNAMICS; RECEPTOR; PROTEIN;
D O I
10.1002/psc.2628
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two glycosylated peptides have been studied using NMR spectroscopy supported by molecular modeling. Peptide I is an oxytocin (OT) analogue in which glutamine 4 was replaced by serine with attached -d-mannose through the oxygen atom, whereas peptide II is a lysine-vasopressin (LVP) analogue with lysine 8 side chain modified by the attachment of glucuronic acid through an amide bond. Both peptides exhibit very weak uterotonic effect and are less susceptible to proteolytic degradation than the mother hormones. Additionally, peptide II reveals very weak pressor and antidiuretic activities. Our results have shown that the conformational preferences of glycosylated analogues are highly similar to those of their respective mother hormones. OT glycosylated analogue (I) exhibits a 3,4 -turn characteristic of OT-like peptides, and vasopressin-glycosylated analogue (II) exhibits-turns typical of vasopressin-like peptides. Therefore, the lack of binding of the glycosylated analogues to the receptors can be attributed to a steric interference between the carbohydrate moieties and the receptors. We also consider this to be the reason of the very low activity of the analyzed glycopeptides. We expect that results from these studies will be helpful in designing new OT-like and vasopressin-like drugs. Copyright (c) 2014 European Peptide Society and John Wiley & Sons, Ltd.
引用
收藏
页码:406 / 414
页数:9
相关论文
共 78 条
[61]   Conformational studies of vasopressin and mesotocin using NMR spectroscopy and molecular modelling methods. Part I: studies in water [J].
Sikorska, Emilia ;
Rodziewicz-Motowidlo, Sylwia .
JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (01) :76-84
[62]   Influence of bulky 3,3′-diphenylalanine enantiomers replacing position 2 of AVP analogues on their conformations: NMR and molecular modeling studies [J].
Sikorska, Emilia ;
Kwiatkowska, Anna ;
Sobolewski, Dariusz ;
Slusarz, Rafal ;
Slusarz, Magdalena J. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) :4065-4073
[63]   Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: Molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system [J].
Slusarz, MJ ;
Slusarz, R ;
Ciarkowski, J .
BIOPOLYMERS, 2006, 81 (05) :321-338
[64]   Molecular dynamics simulation of human neurohypophyseal hormone receptors complexed with oxytocin - modeling of an activated state [J].
Slusarz, MJ ;
Susarz, R ;
Ciarkowski, J .
JOURNAL OF PEPTIDE SCIENCE, 2006, 12 (03) :171-179
[65]   REVERSE TURNS IN PEPTIDES AND PROTEINS [J].
SMITH, JA ;
PEASE, LG .
CRC CRITICAL REVIEWS IN BIOCHEMISTRY, 1980, 8 (04) :315-399
[66]   Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds [J].
Spiro, RG .
GLYCOBIOLOGY, 2002, 12 (04) :43R-56R
[67]   TIME-DEPENDENT DISTANCE RESTRAINTS IN MOLECULAR-DYNAMICS SIMULATIONS [J].
TORDA, AE ;
SCHEEK, RM ;
VANGUNSTEREN, WF .
CHEMICAL PHYSICS LETTERS, 1989, 157 (04) :289-294
[68]  
Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151
[69]   EVOLUTION OF THE VASOPRESSIN OXYTOCIN SUPERFAMILY - CHARACTERIZATION OF A CDNA-ENCODING A VASOPRESSIN-RELATED PRECURSOR, PREPROCONOPRESSIN, FROM THE MOLLUSK LYMNAEA-STAGNALIS [J].
VANKESTEREN, RE ;
SMIT, AB ;
DIRKS, RW ;
DEWITH, ND ;
GERAERTS, WPM ;
JOOSSE, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4593-4597
[70]  
VARGADEFTERDAROVIC L, 1992, INT J PEPT PROT RES, V39, P12